Senior insider sale
Chief Executive Officer at DEFINIUM THERAPEUTICS, INC. — senior position signals high conviction
$591.2K
52.28K shares
What this filing means
BARROW ROBERT plans to sell 52.28K shares of DEFINIUM THERAPEUTICS, INC. valued at approximately $591.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/29/2025ACC: 0001104659-25-124857
DirectorOfficer· Chief Executive Officer
Since Jan 2022
52.28K
Shares to sell
$591.2K
Approx. market value
25.79K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
12/26/2025
25.79KTotal acquired25.79K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/26/2025 | Restricted Stock Vesting Compensation | 25.79K | — |
| Total | 25.79K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
26.49K
Market value
$252.1K
9/25/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
25.79K
Market value
$339.1K
12/26/2025
Total
Units
52.28K
Value
$591.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/25/2025 | 26.49K | $252.1K | — | Completed |
| Planned — Approximate Date | ||||
12/26/2025 | 25.79K | $339.1K | NASDAQ | Planned |
| Total | 52.28K | $591.2K | ||